zotepine and Hyperprolactinaemia studies

zotepine and Hyperprolactinaemia

zotepine has been researched along with Hyperprolactinaemia in 2 studies

zotepine: structure

Research Excerpts

Excerpt	Relevance	Reference
"This was a 6-week, multicenter, randomized, open-label, parallel-group, flexible dosing study."	2.78	An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation. ( Chan, HY; Chen, KP; Chen, YY; Cheng, JS; Lin, AS; Tsai, CJ, 2013)
"The trial was a prospective, open-label, single-center one with a flexible dosing of SGAs."	2.73	Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients. ( Cejpková, A; Rodáková, I; Svestka, J; Synek, O; Tomanová, J, 2007)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (50.00)

29.6817

2010's

1 (50.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Chan, HY	1
Lin, AS	1
Chen, KP	1
Cheng, JS	1
Chen, YY	1
Tsai, CJ	1
Svestka, J	1
Synek, O	1
Tomanová, J	1
Rodáková, I	1
Cejpková, A	1

Studies

Chan, HY

Lin, AS

Chen, KP

Cheng, JS

Chen, YY

Tsai, CJ

Svestka, J

Synek, O

Tomanová, J

Rodáková, I

Cejpková, A

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Multi-centre Comparative Study to Evaluate the Anti-aggression Effect and Safety of Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward[NCT00418873]	Phase 4	39 participants (Actual)	Interventional	2007-03-31	Terminated (stopped due to Study was stopped due to difficulty in patient enrollment)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

A Multi-centre Comparative Study to Evaluate the Anti-aggression Effect and Safety of Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward[NCT00418873]

Phase 4

39 participants (Actual)

Interventional

2007-03-31

Terminated (stopped due to Study was stopped due to difficulty in patient enrollment)

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for zotepine and Hyperprolactinaemia

Article	Year
An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:6 Topics: Acute Disease; Adult; Antipsychotic Agents; Dibenzothiepins; Female; Hospitalization; Humans; Hyperp	2013
Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients. Neuro endocrinology letters, 2007, Volume: 28, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibe	2007

Article

Year

An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.

Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:6

Topics: Acute Disease; Adult; Antipsychotic Agents; Dibenzothiepins; Female; Hospitalization; Humans; Hyperp

2013

Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.

Neuro endocrinology letters, 2007, Volume: 28, Issue:6

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibe

2007